RxDoctor Payments Data

Michael Nissen

Family · Raeford, NCNPI 1417077827

Payments from drug & device makers

$6,468in general payments, 2019–2025

Across 318 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$953
  • Lilly USA, LLC$576
  • Boehringer Ingelheim$575
  • Merck$395
  • Johnson & Johnson$342
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$6,443100%
  • Education$250%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,468 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol38$31,166
JardianceEmpagliflozin28$18,812
XareltoRivaroxaban18$12,273
Atorvastatin Calcium179$1,863
Amlodipine-ValsartanAmlodipine Besylate/Valsartan12$1,139
Omeprazole77$1,068
Amlodipine Besylate143$877
Losartan Potassium43$664
Gabapentin32$483
Pantoprazole Sodium32$468
Alendronate Sodium34$455
Lisinopril98$441
Levothyroxine Sodium45$418
Rosuvastatin Calcium39$409
Potassium Chloride24$375

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$1,279$31,16638 claims
Boehringer IngelheimJardiance$575$18,81228 claims
Johnson & JohnsonXarelto$342$12,27318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,522 family providers in North Carolina.

Other family in Raeford

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →